SOPHiA GENETICS, a precision-medicine company listed on Nasdaq (SOPH), announces the pricing of its previously announced underwritten public offering. According to the reports, the company prices the offering at $4.75 per ordinary share. The public offering consists of 10,526,000 ordinary shares, sold at the stated public offering price. The company’s announcement also frames the transaction as a $50 million public offering, aligning with the share count and per-share price cited by sources. The offering is underwritten, and the company indicates that the final terms follow the pricing announcement. The outlets do not provide additional details in the excerpts provided on expected closing timing, use of proceeds, or whether the offering includes any options for underwriters. Overall, the shared information centers on the number of shares and the per-share price that determine the total offering value.